News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Daily News Many Young Patients With AR Do Not Achieve LV Normalization With Surgery L.A. McKeown September 26, 2023
News Daily News Journal Series Explores How Eroding Abortion Access Impacts the HF Community Todd Neale June 15, 2023
News Conference News ACC 2023 Studies Support (Careful) Return to Sport for Athletes With Genetic Conditions Michael O'Riordan March 07, 2023
News Daily News Good Results For TAVI in Bicuspid Valves, but Questions Persist Michael O'Riordan March 08, 2022
News Daily News Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR Caitlin E. Cox February 22, 2022
News Daily News Complete Anesthesia Handover in Cardiac Surgery Leads to Worse Outcomes Michael O'Riordan February 16, 2022
News Daily News FDA Approves Two Additional Indications for Rivaroxaban in Children L.A. McKeown December 21, 2021
News Daily News Genetic Testing for CVD in Children: AHA Statement Suggests Focus on Multidisciplinary Care Yael L. Maxwell September 01, 2021
News Daily News Clopidogrel Only Needed for 3 Months After ASD Closure: CANOA Analysis Caitlin E. Cox September 23, 2020
News Features Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers? Yael L. Maxwell August 02, 2019
News Daily News FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients Yael L. Maxwell May 16, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News ACC 2019 TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients Yael L. Maxwell March 17, 2019
News Daily News Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease Caitlin E. Cox January 07, 2019